Measles & Rubella Weekly Monitoring Report: November 16 to November 22, 2014 (week 47)
Key Points
- In Canada, no new cases of measles were reported during week 47.
- On November 13, the World Health Organization issued a news release warning that international progress towards measles elimination has stalled. Agreed to at the 2010 World Health Assembly, milestones for 2015 (related to increasing immunization coverage and decreasing measles incidence and mortality) may not be metFootnote 1.
- Pakistan continues to experience a high level of measles activity with 1288 confirmed cases reported so far this yearFootnote 2.
On this page
Organization:
Epidemiological Summary
Figure 1. Number of cases measles (n=127) and rubella (n=1), by week of rash onset, as reported to the Canadian Measles/ Rubella Surveillance System (CMRSS) and Measles and Rubella Surveillance system (MARS), for the period ending November 22, 2014. Among these, rash onset is not currently available for 25 cases; they have been excluded from the figure but included in the year-to-date total below.
Figure 1 - Text Description
Epidemiological Week of Rash Onset, 2014 | Number of confirmed measles cases reported | Number of confirmed rubella cases reported |
---|---|---|
1 | 1 | 0 |
2 | 1 | 0 |
3 | 5 | 0 |
4 | 7 | 0 |
5 | 2 | 0 |
6 | 4 | 0 |
7 | 1 | 0 |
8 | 0 | 0 |
9 | 2 | 0 |
10 | 2 | 1 |
11 | 4 | 0 |
12 | 4 | 0 |
13 | 11 | 0 |
14 | 7 | 0 |
15 | 8 | 0 |
16 | 4 | 0 |
17 | 13 | 0 |
18 | 3 | 0 |
19 | 2 | 0 |
20 | 1 | 0 |
21 | 5 | 0 |
22 | 5 | 0 |
23 | 1 | 0 |
24 | 3 | 0 |
25 | 1 | 0 |
26 | 1 | 0 |
27 | 0 | 0 |
28 | 0 | 0 |
29 | 0 | 0 |
30 | 0 | 0 |
31 | 1 | 0 |
32 | 1 | 0 |
33 | 0 | 0 |
34 | 0 | 0 |
35 | 1 | 0 |
36 | 1 | 0 |
37 | 0 | 0 |
38 | 0 | 0 |
39 | 0 | 0 |
40 | 0 | 0 |
41 | 0 | 0 |
42 | 0 | 0 |
43 | 0 | 0 |
44 | 0 | 0 |
45 | 0 | 0 |
46 | 0 | 0 |
47 | 0 | 0 |
48 | 0 | 0 |
49 | 0 | 0 |
50 | 0 | 0 |
51 | 0 | 0 |
52 | 0 | 0 |
Missing Rash Onset | 25 | 0 |
Cases (year-to-date) | 127 | 1 |
During epidemiological week 47, 2014, no new cases of measles were reported in Canada.
The year-to-date totalFootnote 3 is 127 cases of measles and 1 case of rubella for 2014.
Geographic Distribution
Figure 2: Distribution of confirmed measles and rubella cases by health region. Cases are included if they are considered active.Figure 2 - Footnote *
- Figure 2 - Footnote 1
-
Active cases or outbreaks are those in which the onset date of the most recent case/outbreak-associated case falls within 32 days of the issue date of this reportFootnote 4.
Figure 2 - Text Description
Health Region | Measles Cases | Rubella Cases |
---|---|---|
Eastern Regional Integrated Health Authority | 0 | 0 |
Central Regional Integrated Health Authority | 0 | 0 |
Western Regional Integrated Health Authority | 0 | 0 |
Labrador-Grenfell Regional Integrated Health Authority | 0 | 0 |
Prince Edward Island | 0 | 0 |
South Shore District Health Authority | 0 | 0 |
South West Nova District Health Authority | 0 | 0 |
Annapolis Valley District Health Authority | 0 | 0 |
Colchester East Hants Health Authority | 0 | 0 |
Cumberland Health Authority | 0 | 0 |
Pictou County Health Authority | 0 | 0 |
Guysborough Antigonish Strait Health Authority | 0 | 0 |
Cape Breton District Health Authority | 0 | 0 |
Capital District Health Authority | 0 | 0 |
Zone 1 (NB) | 0 | 0 |
Zone 2 (NB) | 0 | 0 |
Zone 3 (NB) | 0 | 0 |
Zone 4 (NB) | 0 | 0 |
Zone 5 (NB) | 0 | 0 |
Zone 6 (NB) | 0 | 0 |
Zone 7 (NB) | 0 | 0 |
Québec et Chaudières-Appalaches | 0 | 0 |
Centre-du-Québec | 0 | 0 |
Montréal et Laval | 0 | 0 |
Ouest-du-Québec | 0 | 0 |
Montérégie | 0 | 0 |
Nord-Est | 0 | 0 |
Ontario Central East | 0 | 0 |
Ontario Central West | 0 | 0 |
Ontario Eastern | 0 | 0 |
Ontario North East | 0 | 0 |
Ontario North West | 0 | 0 |
Ontario South West | 0 | 0 |
City of Toronto Health Unit | 0 | 0 |
Winnipeg Regional Health Authority | 0 | 0 |
Prairie Mountain Health | 0 | 0 |
Interlake-Eastern Regional Health Authority | 0 | 0 |
Northern Regional Health Authority | 0 | 0 |
Southern Health | 0 | 0 |
Saskatchewan South | 0 | 0 |
Saskatchewan Central | 0 | 0 |
Saskatchewan North | 0 | 0 |
South Zone | 0 | 0 |
Calgary Zone | 0 | 0 |
Central Zone | 0 | 0 |
Edmonton Zone | 0 | 0 |
North Zone | 0 | 0 |
British Columbia Interior | 0 | 0 |
British Columbia Fraser | 0 | 0 |
British Columbia Vancouver Coastal | 0 | 0 |
British Columbia Vancouver Island | 0 | 0 |
British Columbia Northern | 0 | 0 |
Yukon | 0 | 0 |
Northwest Territories | 0 | 0 |
Nunavut | 0 | 0 |
Laboratory Summary
Measles
Genotyping is pending for 0 cases.
For 2014, measles genotype information is available for 111 of 127 reported cases and the genotypes were: B3 (n=65), D8 (n=36), D9 (n=5), H1 (n=3), and D4 (n=2).
Figure 3: Distribution of measles genotypes detected in 2014 (n=111) by week of rash onset (if available, n=85) or specimen collection (n=26). Epidemiological weeks are assigned in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year.
* Genotype B3 sequences identical to sequence variant MVi/Harare.ZWE/38.09 (GenBank accession number JF973033)
† Genotype D8 sequences identical to sequence variant MVs/Taunton.GBR/27.12 (GenBank accession number JX984461)
Figure 3 - Text Description
Epi week | B3 | B3 - Harare | D4 | D8 | D8 - Taunton | D9 | H1 | Total |
---|---|---|---|---|---|---|---|---|
1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
2 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 5 |
3 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 7 |
4 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 3 |
5 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 3 |
6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 |
9 | 1 | 2 | 0 | 0 | 3 | 0 | 0 | 6 |
10 | 0 | 1 | 0 | 0 | 6 | 0 | 0 | 7 |
11 | 1 | 1 | 0 | 0 | 7 | 0 | 0 | 9 |
12 | 2 | 5 | 0 | 0 | 7 | 0 | 0 | 14 |
13 | 1 | 0 | 0 | 1 | 5 | 0 | 0 | 7 |
14 | 2 | 2 | 1 | 0 | 1 | 4 | 0 | 10 |
15 | 0 | 4 | 0 | 0 | 0 | 1 | 1 | 6 |
16 | 1 | 3 | 1 | 1 | 4 | 0 | 1 | 11 |
17 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 2 |
18 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 5 |
21 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 3 |
22 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
23 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
24 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
25 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
31 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
34 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 55 | 2 | 2 | 34 | 5 | 3 | 111 |
The current global distribution of measles genotypes can be found on the WHO Measles Nucleotide Surveillance (MeaNS) website.
For information regarding the interpretation and use of measles genotyping (including a discussion of genotypes and sequence variants), refer to Hiebert J and Severini A. Canada Communicable Disease Report. 2014; 40-12: 257- 260.
Footnotes
Page details
- Date modified: